With the recent increase in use of anti-PD-1 antibody for patients with various types of cancers, clarification of the underlying mechanisms and development of more efficacious treatment for PD-1 signal blockade-induced psoriasis-like dermatitis is needed. This evidence concerns the gene PDCD1 and skin disorder.